Pfizer, BioNTech report 80 percent efficacy of Covid-19 vaccine for youngest children

Pfizer and BioNTech announced today that they plan to submit data to the Food and Drug Administration for three doses of their Covid-19 vaccine for children at least 6 months old up to children under 5 years old.

The companies released top-line results showing that three pediatric doses of their Covid-19 vaccine generated a comparable immune response in children as two full doses did in young adults — the primary end goal the FDA set

→ Continue reading at Politico

[ufc-fb-comments url=""]

Latest Articles

Related Articles